BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5353507)

  • 1. The proteolytic action of arvin on human fibrinogen.
    Ewart MR; Hatton M; Basford JM; Dodgson KS
    Biochem J; 1969 Nov; 115(3):17P. PubMed ID: 5353507
    [No Abstract]   [Full Text] [Related]  

  • 2. The proteolytic action of Arvin on human fibrinogen.
    Ewart MR; Hatton MW; Basford JM; Dodgson KS
    Biochem J; 1970 Jul; 118(4):603-9. PubMed ID: 5529716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of peptides released from human fibrinogen by Arvin.
    Holleman WH; Coen LJ
    Biochim Biophys Acta; 1970 Mar; 200(3):587-9. PubMed ID: 5461758
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arvin, a new anticoagulant].
    Leube G
    Thromb Diath Haemorrh Suppl; 1973; 55():199-219. PubMed ID: 4807850
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of chemical inhibitors and ionizing radiation on arvin activity.
    Beamont KP; Phillips GO; Power DM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1972 Aug; 22(2):137-48. PubMed ID: 4538219
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformational changes of IRC-50 arvin at high pH.
    Collins JP
    Biochem J; 1972 Jul; 128(4):132P. PubMed ID: 4638776
    [No Abstract]   [Full Text] [Related]  

  • 8. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states.
    Sanchez-Avalos J; Miller SP
    Thromb Diath Haemorrh; 1968 Jul; 19(3):499-515. PubMed ID: 4974324
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of arvin on blood platelets. In vitro and in vivo studies.
    Brown CH; Bell WR; Shreiner DP; Jackson DP
    J Lab Clin Med; 1972 May; 79(5):758-69. PubMed ID: 5018740
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic proteases from snake venoms].
    Kornalik F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):193-208. PubMed ID: 4106009
    [No Abstract]   [Full Text] [Related]  

  • 13. [EFFECT OF SNAKE VENOMS ON BLOOD COAGULATION IN VITRO].
    KORNALIK F
    Acta Univ Carol Med (Praha); 1963; 9():149-88. PubMed ID: 14166155
    [No Abstract]   [Full Text] [Related]  

  • 14. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of proteolytic activities in the venoms of some North American snakes.
    Wagner FW; Prescott JM
    Comp Biochem Physiol; 1966 Jan; 17(1):191-201. PubMed ID: 4957299
    [No Abstract]   [Full Text] [Related]  

  • 16. The interaction between fibrinogen and 3H-L-arginine cationic peptides derived from fibrosarcoma in the presence of thrombin.
    Farbiszewski R; Sokól A
    Haematologia (Budap); 1988; 21(3):169-73. PubMed ID: 3053360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Arvin with erythrocyte flexibility.
    Myers P; Rampling MW; Sirs JA
    J Physiol; 1973 Apr; 230(1):51P-52P. PubMed ID: 4702445
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.
    Kakkar VV; Flanc C; Howe CT; O'Shea M; Flute PT
    Br Med J; 1969 Mar; 1(5647):806-10. PubMed ID: 4886628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation products of fibrinogen and crosslinked fibrin-projected clinical applications.
    Marder VJ; Budzynski AZ
    Thromb Diath Haemorrh; 1974 Sep; 32(1):49-56. PubMed ID: 4616425
    [No Abstract]   [Full Text] [Related]  

  • 20. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.